Check eligibility
Answer a brief 2-minute questionnaire about your health profile and goals.

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.
Couldn't load pickup availability
Pickup available at Medetone LLC
Usually ready in 24 hoursPairs well with
Type of Medicine
GLP-1 receptor agonist
Generic
No
Active Ingredient
Semaglutide
Effective Within
Within a few weeks.
Works By
Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.
Side Effects
Nausea, diarrhea, hypoglycemia (low blood sugar), stomach discomfort, and gastrointestinal upset.
Wegovy (semaglutide) tablet is a once-daily oral prescription medication for weight management in adults with obesity or overweight-related health conditions. This GLP-1 receptor agonist reduces appetite and promotes satiety. Clinical studies show an average weight loss of 16.6% over 64 weeks. Available in multiple strengths with no refrigeration required. Use alongside a reduced-calorie diet and regular exercise for optimal results. Consult your healthcare provider regarding eligibility and prescribing information.
The main ingredient in Wegovy is semaglutide. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. This means it mimics the action of natural hormones that regulate appetite and food intake in the body. GLP-1 receptor agonists work by reducing hunger and increasing feelings of fullness, leading to decreased food intake and, consequently, weight loss. Semaglutide is administered via injection and is designed to be used alongside a reduced-calorie diet and increased physical activity for the management of obesity or overweight in adults with certain weight-related medical conditions.

GLP-1 receptor agonists are transforming the way we approach weight loss. Originally developed to help people with type 2 diabetes, these medications have since gained widespread approval for their effectiveness in weight management.
GLP-1 weight loss treatments work by mimicking natural hormones that help regulate appetite, slow digestion, and promote a feeling of fullness. Making it easier to reduce caloric intake and support sustainable weight loss.

Weight loss medications targeting GLP-1 receptors offer clinically proven results for individuals with obesity or weight-related health issues. These treatments are not quick fixes. They are part of a long-term medical strategy designed to support a healthier lifestyle.
By reducing hunger signals and increasing feelings of fullness, GLP-1 therapies can help patients lose a significant percentage of their body weight when combined with lifestyle changes.
For those who have had limited success with diet and exercise alone, GLP-1–based products represent a modern and effective alternative, approved by regulatory authorities across the US.
Real people. Real progress. Real support.
A simple online process, designed to be clear from start to finish.
Answer a brief 2-minute questionnaire about your health profile and goals.
A certified New York physician evaluates your information to find the right plan for you within 24 hours.
Next-day delivery across New York, with support at every step of your treatment.
Check eligibility